Notable Labs (NASDAQ:NTBL – Free Report) had its target price trimmed by Chardan Capital from $9.00 to $7.00 in a report published on Monday morning, Benzinga reports. The brokerage currently has a buy rating on the stock.
Separately, JMP Securities lowered their price objective on Notable Labs from $13.00 to $9.00 and set a market outperform rating on the stock in a research note on Tuesday, December 19th.
View Our Latest Analysis on NTBL
Notable Labs Stock Down 2.5 %
Institutional Investors Weigh In On Notable Labs
A hedge fund recently bought a new stake in Notable Labs stock. Industry Ventures L.L.C. acquired a new stake in Notable Labs, Ltd. (NASDAQ:NTBL – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 204,424 shares of the company’s stock, valued at approximately $386,000. Notable Labs accounts for approximately 0.6% of Industry Ventures L.L.C.’s investment portfolio, making the stock its 6th largest holding. Industry Ventures L.L.C. owned approximately 9.21% of Notable Labs as of its most recent filing with the SEC. Institutional investors own 70.48% of the company’s stock.
About Notable Labs
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic.
Featured Stories
- Five stocks we like better than Notable Labs
- Golden Cross Stocks: Pattern, Examples and Charts
- United Airlines Soars on Earnings Beat
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- J.B. Hunt Hits the Skids: Lower Prices to Come
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with MarketBeat.com's FREE daily email newsletter.